Seshadri Neervannan
Overview
Seshadri Neervannan received $2M in total compensation, including $500K in salary, at Tarsus Pharmaceuticals in 2023.
Source: SEC filing on April 26, 2024.
Related executives
We found six more executives who work or worked at Tarsus Pharmaceuticals.
Jeffrey Farrow
Tarsus Pharmaceuticals
Chief Financial Officer
Bobak Azamian
Tarsus Pharmaceuticals
Chief Executive Officer
Leonard Greenstein
Tarsus Pharmaceuticals
Chief Financial Officer
Jose Trevejo
Tarsus Pharmaceuticals
Chief Medical Officer
Bryan Wahl
Tarsus Pharmaceuticals
General Counsel
Dianne MSW
Tarsus Pharmaceuticals